Accelerate COVID-19 research with new insights from world-class proteomics
What if you could use an open hypothesis approach that allowed you to rapidly study the plasma proteome in a robust and high throughput mode to find correlations between protein biomarkers and disease, understand what biological pathways are involved and identify markers of disease stage, prognosis severity and immunological response etc? Together with analysis of related comorbidities, this could enable the assessment of multiple risk factors for severe COVID-19, provide tools with which to monitor patients and identify potential new drug targets.
Take a look at our infographic to see what Olink has done, is doing and can do in the near future to accelerate COVID-19 research!